ASSESSMENT OF THE CARDIOPROTECTIVE EFFICACY OF DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Authors

  • Sadikova Nigora Gayratovna Candidate of Medical Sciences
  • Ashurova Nazifa Gayratovna Postgraduate Specialist in Endocrinology Tashkent Medical Academy

Keywords:

Dulaglutide, GLP-1 RA, cardiovascular system, type 2 diabetes mellitus, glycated hemoglobin (HbA1C)

Abstract

According to the latest data from the FDA (Food and Drug Administration), approximately 537 million people worldwide are affected by diabetes (98% of them with type 2 diabetes).

Downloads

Published

2025-02-24

Issue

Vol. 6 No. 2 (2025): wos

Section

Articles

License

Copyright (c) 2025 Web of Scientist: International Scientific Research Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.